- Home
- SSB vs LEGN Comparison
SSB vs LEGN Comparison
Compare SSB & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSB
- LEGN
- Stock Information
- Founded
- SSB 1933
- LEGN 2014
- Country
- SSB United States
- LEGN United States
- Employees
- SSB N/A
- LEGN N/A
- Industry
- SSB Major Banks
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- SSB Finance
- LEGN Health Care
- Exchange
- SSB Nasdaq
- LEGN Nasdaq
- Market Cap
- SSB 7.0B
- LEGN 7.8B
- IPO Year
- SSB 1997
- LEGN 2020
- Fundamental
- Price
- SSB $100.21
- LEGN $34.08
- Analyst Decision
- SSB Buy
- LEGN Strong Buy
- Analyst Count
- SSB 9
- LEGN 13
- Target Price
- SSB $108.00
- LEGN $81.54
- AVG Volume (30 Days)
- SSB 584.5K
- LEGN 1.5M
- Earning Date
- SSB 01-23-2025
- LEGN 11-12-2024
- Dividend Yield
- SSB 2.15%
- LEGN N/A
- EPS Growth
- SSB N/A
- LEGN N/A
- EPS
- SSB 6.48
- LEGN N/A
- Revenue
- SSB $1,667,615,000.00
- LEGN $520,183,000.00
- Revenue This Year
- SSB N/A
- LEGN $120.77
- Revenue Next Year
- SSB $41.64
- LEGN $68.54
- P/E Ratio
- SSB $15.46
- LEGN N/A
- Revenue Growth
- SSB 2.44
- LEGN 122.96
- 52 Week Low
- SSB $70.68
- LEGN $32.50
- 52 Week High
- SSB $114.27
- LEGN $70.13
- Technical
- Relative Strength Index (RSI)
- SSB 36.39
- LEGN 31.74
- Support Level
- SSB $106.76
- LEGN $32.50
- Resistance Level
- SSB $109.66
- LEGN $35.08
- Average True Range (ATR)
- SSB 3.01
- LEGN 1.98
- MACD
- SSB -1.50
- LEGN -0.51
- Stochastic Oscillator
- SSB 13.70
- LEGN 13.10
About SSB SouthState Corporation
SouthState Corp is a United States-based bank holding company. It provides a wide range of banking services and products to its customers through a wholly-owned bank subsidiary, South State Bank. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time and savings deposits, lending and credit cards servicing, ATM processing, and wealth management and trust services.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.